On Sept. 1, 2020, Arcadia Biosciences announced it had completed the purchase of Oregon-based Industrial Seed Innovations (ISI) specializing in organically grown, high CBD feminized hemp seed and seedlings.

With this acquisition, ISI’s portfolio of strong performing, federally compliant hemp varieties have become part of Arcadia’s GoodHemp™ line of hemp seeds, transplants and extracts. ISI’s popular Umpqua and Rogue seed varieties each bring unique and highly desirable characteristics to further differentiate Arcadia’s GoodHemp catalog:

Umpqua: High yielding and CBD dominant, Umpqua is ideal for the smokable and extraction markets. Umpqua is designed to mature earlier than most existing varieties making it very attractive for northern latitudes. Rogue: Also CBD dominant, Rogue is designed to flower and mature later in the season, resulting in ultra-high yielding plants in lower latitudes with longer growing seasons.

The deal solidifies Arcadia’s plans to accelerate the commercialization of its hemp-related breeding platform and establish a research and development facility in the Pacific Northwest, a key hemp production area.

In order to service existing ISI customers and Arcadia’s growing cohort of elite hemp cultivators, the company has deployed a multigenerational team of five regional GoodHemp sales agronomists to support existing growers and expand Arcadia’s seed offerings to new territories. This includes states with recent USDA-approved hemp plans including Florida, Arizona, Minnesota, Texas and Mississippi.